return to the Course index

previous | next

One approach is to use the population values for Vm and Km. For phenytoin we could use population values of Vm = 7 mg/kg/day and Km = 5 mg/L. Aiming at 15 mg/L for Cp_{average} with a patient weight of 80 kg Equation 21.5.1. can be used to estimate the 'first' dose.

**Equation 21.5.1 Dosing Rate versus Cp _{average}**

Probably better to start out low since toxicity is more probable above 20 mg/L.

or

thus a new dose rate can be calculated

approximately 400 mg/day. **Note**: A reduction in dose of 20 mg/day (5 %) is calculated to give a 5 mg/L change (25 %) in Cp_{average}.

Another approach at this point could be the use of the "Orbit Graph" method described by Tozer and Winter, 1992, redrawn from Vozeh, S. 1981. This method uses data previously derived from a patient population to construct shapes, orbit representing 50, 75, 90,95 and 97.5% of the population values of Vm and Km. Plotting this information with one data point allows the estimation of a second doing regimen.

If we already have two steady state plasma concentrations after two different dose rates we can solve Equation 21.5.1 for the two parameters, Vm and Km. This assumes that the patient is fully compliant.

using simultaneous equations.

With Cp_{average, 1} = 8.0 mg/L and Cp_{average, 2} = 27.0 mg/L for R1 = 225 mg/day and R2 = 300 mg/day

225 • Km + 225 • 8 = 8 • Vm (1)

and

300 • Km + 300 • 27 = 27 • Vm (2)

or multiplying (1) x 300

300 • 225 • Km + 300 • 225 • 8 = 300 • 8 • Vm (3)

and multiplying (2) x 225

300 • 225 • Km + 300 • 225 • 27 = 225 • 27 • Vm (4)

subtracting (4) - (3)

300 • 225 • (27 - 8) = (225 • 27 - 300 • 8) • Vm

and

With these Vm and Km values we can now calculate a new, better dosing regimen.

**Error Message** Value is not a numeric literal probably means that one of the parameter fields is empty or a value is inappropriate.

There are a number of graphical methods which have been described for when you have data from two or more dosing intervals. Basically these rely on converting the equations mentioned above into a straight line form which can be plotted to give the Vm and Km as a function of the intercept and/or slope. Again, steady state, average concentrations are required with the patient fully compliant. Some of these methods have been reviewed by Mullen and Foster, 1979. They found that iterative computer analysis was the best method, followed by a plot of Cp_{average} versus Cp_{average}/Dose (Equation 21.5.2), and this was followed by a direct linear plot method. Since the direct linear plot method was the least complicated and required no calculations these authors thought it should be quite useful.

**Equation 21.5.2 Equation for Cp _{average} versus Cp_{average}/Dose**

**Figure 21.5.1 Linear plot of Dose, Vm versus Km, Cp _{average}**

After a dose of 256 mg/day and 333 mg/day the steady state Cp_{average} values were measured to be 7 and 20 mg/L, respectively. These data are represented as the red and blue lines, respectively. These lines intercept at 4,400 which provide a value of Km and Vm of 4mg/L and 400 mg/day, respectively. If we were aiming for a Cp_{average} value of 15 mg/L this point on the x-axis could be connected with the intersection of the red and blue lines by drawing the green line. The intersection of the green line with the y-axis provides the required dose of 316 mg/day. Various dose and expected Cp_{average} could be estimated from the intersection of the red and blue lines.

Want more practice with this type of problem!

- Tozer, T.N. and Winter, M.E. 1992 Chapter 25, "Phenytoin" in
**Applied Pharmacokinetics**, 3rd. ed., Evans, W.E., Schentag, J.J., and Jusko, W.J. ed., Applied Therapeutics, San Francisco, CA Figure 25-11, p 25-31 - Vozeh, S. et al. 1981 Predicting individual phenytoin dosage,
*J. Pharmacokin. Biopharm.*,**9**, 131-146 - Mullen, P.W. and Foster, R.W. 1979 Comparative evaluation of six techniques for determining the Michaelis-Menten parameters relating phenytoin dose and steady-state serum concentrations,
*J. Pharm. Pharmacol.*,**31**, 100-104

This page was last modified: Wednesday, 18th Oct 2017 at 6:35 pm

Privacy Statement - 25 May 2018

Material on this website should be used for Educational or Self-Study Purposes Only

iBook and pdf versions of this material and other PK material is available

Copyright © 2001-2019 David W. A. Bourne (david@boomer.org)